Search

everythinglearnresearchcommunity

for

Search:↓

Traditional healers in Namibia use 70 different plants to treat AIDS-related diseases, and more research is needed to test these plants' effectiveness against HIV.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

The document concludes that pig iPSCs show promise for transplant therapies and the field is advancing in controlling cell behavior for biology and medicine.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Finasteride may lower cholesterol and slow heart disease progression.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Flutamide rarely causes liver toxicity in prostate cancer patients.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Using steroids can increase the risk of heart problems.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Ban Tu Wan, a Chinese herbal supplement, can cause severe liver damage.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.